These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12915880)

  • 1. Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population.
    Nakazato H; Suzuki K; Matsui H; Ohtake N; Nakata S; Yamanaka H
    Br J Cancer; 2003 Aug; 89(4):691-6. PubMed ID: 12915880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the RNASEL gene in familial and sporadic prostate cancer.
    Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
    Am J Hum Genet; 2002 Jul; 71(1):116-23. PubMed ID: 12022038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNASEL gene polymorphisms and the risk of prostate cancer: a meta-analysis.
    Li H; Tai BC
    Clin Cancer Res; 2006 Oct; 12(19):5713-9. PubMed ID: 17020975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.
    Wei B; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Yan Z; Xuan F; Zhou H; Huang X; Zhang J; Lu P; Shao J
    Mol Biol Rep; 2012 Mar; 39(3):2347-53. PubMed ID: 21656378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.
    Krüger S; Silber AS; Engel C; Görgens H; Mangold E; Pagenstecher C; Holinski-Feder E; von Knebel Doeberitz M; Moeslein G; Dietmaier W; Stemmler S; Friedl W; Rüschoff J; Schackert HK;
    Lancet Oncol; 2005 Aug; 6(8):566-72. PubMed ID: 16054567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNASEL Arg462Gln polymorphism and prostate cancer in PLCO.
    Daugherty SE; Hayes RB; Yeager M; Andriole GL; Chatterjee N; Huang WY; Isaacs WB; Platz EA
    Prostate; 2007 Jun; 67(8):849-54. PubMed ID: 17407163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.
    Rökman A; Ikonen T; Seppälä EH; Nupponen N; Autio V; Mononen N; Bailey-Wilson J; Trent J; Carpten J; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
    Am J Hum Genet; 2002 May; 70(5):1299-304. PubMed ID: 11941539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.
    Agalliu I; Leanza SM; Smith L; Trent JM; Carpten JD; Bailey-Wilson JE; Burk RD
    Prostate; 2010 Nov; 70(15):1716-27. PubMed ID: 20564318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.
    Maier C; Haeusler J; Herkommer K; Vesovic Z; Hoegel J; Vogel W; Paiss T
    Br J Cancer; 2005 Mar; 92(6):1159-64. PubMed ID: 15714208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNASEL germline variants are associated with pancreatic cancer.
    Bartsch DK; Fendrich V; Slater EP; Sina-Frey M; Rieder H; Greenhalf W; Chaloupka B; Hahn SA; Neoptolemos JP; Kress R
    Int J Cancer; 2005 Dec; 117(5):718-22. PubMed ID: 15981205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of RNASEL and 8q24 variants with the presence and aggressiveness of hereditary and sporadic prostate cancer in a Hispanic population.
    San Francisco IF; Rojas PA; Torres-Estay V; Smalley S; Cerda-Infante J; Montecinos VP; Hurtado C; Godoy AS
    J Cell Mol Med; 2014 Jan; 18(1):125-33. PubMed ID: 24224612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
    Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA
    Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
    Fesinmeyer MD; Kwon EM; Fu R; Ostrander EA; Stanford JL
    Prostate; 2011 Oct; 71(14):1538-47. PubMed ID: 21360564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.
    Shook SJ; Beuten J; Torkko KC; Johnson-Pais TL; Troyer DA; Thompson IM; Leach RJ
    Clin Cancer Res; 2007 Oct; 13(19):5959-64. PubMed ID: 17908993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
    Rennert H; Zeigler-Johnson CM; Addya K; Finley MJ; Walker AH; Spangler E; Leonard DG; Wein A; Malkowicz SB; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):949-57. PubMed ID: 15824169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in RNASEL associated with prostate cancer risk and progression.
    Meyer MS; Penney KL; Stark JR; Schumacher FR; Sesso HD; Loda M; Fiorentino M; Finn S; Flavin RJ; Kurth T; Price AL; Giovannucci EL; Fall K; Stampfer MJ; Ma J; Mucci LA
    Carcinogenesis; 2010 Sep; 31(9):1597-603. PubMed ID: 20576793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arg462Gln and Asp541Glu polymorphisms in ribonuclease L and prostate cancer risk: a meta-analysis.
    Mi Y; Yu Q; Min Z; Xu B; Zhang L; Zhang W; Feng N; Hua L
    J Biomed Res; 2010 Sep; 24(5):365-73. PubMed ID: 23554651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.
    Casey G; Neville PJ; Plummer SJ; Xiang Y; Krumroy LM; Klein EA; Catalona WJ; Nupponen N; Carpten JD; Trent JM; Silverman RH; Witte JS
    Nat Genet; 2002 Dec; 32(4):581-3. PubMed ID: 12415269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer.
    Wiklund F; Jonsson BA; Brookes AJ; Strömqvist L; Adolfsson J; Emanuelsson M; Adami HO; Augustsson-Bälter K; Grönberg H
    Clin Cancer Res; 2004 Nov; 10(21):7150-6. PubMed ID: 15534086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans.
    Shea PR; Ishwad CS; Bunker CH; Patrick AL; Kuller LH; Ferrell RE
    Prostate; 2008 Mar; 68(4):354-9. PubMed ID: 18189233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.